Concepedia
Statistics
Publications
12
Citations
257
H-Index
Active since
1992
Affiliations
Massachusetts Institute of Technology(Current)
Boehringer Ingelheim (United States)
Boehringer Ingelheim (Germany)
Medical University of Vienna
Leipzig University
Roman Fleck is an author at Massachusetts Institute of Technology specializing in pharmacy, medicinal chemistry, and pharmacology.
Publications per year
1992–2024
Substituted pyrazoles as novel sEH antagonist: Investigation of key binding interactions within the catalytic domain
Ho Yin Lo, Chuk C. Man, Roman Fleck et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 41 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +15
The discovery of thienopyridine analogues as potent IκB kinase β inhibitors. Part II
Jiang‐Ping Wu, Roman Fleck, Janice R. Brickwood et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 32 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin
L. Milas, I Nishiguchi, Nancy Hunter et al. · Advances in Space Research · 1992 · 28 citations
Medicine, Pharmacology, Radiation Oncology +16
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma
Helena Sorger, Saptaswa Dey, Pablo Vieyra-Garcia et al. · EMBO Molecular Medicine · 2022 · 28 citations · Full text
Medicine, Cancer Biology, Oncology +11
2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket
Ho Yin Lo, Jörg Bentzien, Roman Fleck et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 22 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
1–5 of 12